Clinical Trials Logo

Clinical Trial Summary

Background: Multiple drug hypersensitivity syndrome (MDH) is defined as confirmed drug hypersensitivity reactions (DHRs) to at least 2 chemically and pharmacologically unrelated drugs. Reports of MDH are scarce and poorly specified and studies which diagnose MDH on the basis of positive allergy tests are lacking.

Objective: To evaluate retrospectively the frequency and characteristics of MDH patients in a large database.

Methods: All the patients who consulted and were tested in our Allergy Unit between September 1996 and February 2018, with confirmed MDH will be included. Clinical history and allergy work-up results will be extracted from our Drug Allergy and Hypersensitivity Database (DAHD). The frequency of MDH will be calculated, MDH patients will be described, the most frequent associations of DHRs will be identified and analysed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03784482
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date December 20, 2018
Completion date July 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT05706246 - Perioperative Hypersensitivity in Children N/A
Recruiting NCT04920721 - Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy
Completed NCT02118987 - Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization Phase 1
Enrolling by invitation NCT03164044 - Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Completed NCT02094638 - Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study N/A
Recruiting NCT05820802 - High Dimensional Analysis of Immune Cells in Pediatric Patients